Transcriptional networks implicated in human nonalcoholic fatty liver disease

被引:15
|
作者
Ye, Hua [1 ]
Liu, Wei [2 ,3 ]
机构
[1] Lihuili Hosp, Dept Gastroenterol, Ningbo Med Treatment Ctr, Ningbo 315040, Zhejiang, Peoples R China
[2] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou 350002, Peoples R China
[3] Inst Aviat Med Chinese PLA Air Force, Dept Pathol, Human Centrifuge Med Training Ctr, Beijing 100089, Peoples R China
基金
中国国家自然科学基金;
关键词
Nonalcoholic fatty liver disease; Transcriptome; Gene co-expression network; Hub gene; microRNA; HEPATIC GENE-EXPRESSION; GENOME-WIDE ASSOCIATION; HEPATOCELLULAR-CARCINOMA; METABOLIC SYNDROME; STEATOHEPATITIS; OBESITY; MICRORNA; SYSTEM; METHYLATION; SIGNATURES;
D O I
10.1007/s00438-015-1037-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptome of nonalcoholic fatty liver disease (NAFLD) was investigated in several studies. However, the implications of transcriptional networks in progressive NAFLD are not clear and mechanisms inducing transition from nonalcoholic simple fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) are still elusive. The aims of this study were to (1) construct networks for progressive NAFLD, (2) identify hub genes and functional modules in these networks and (3) infer potential linkages among hub genes, transcription factors and microRNAs (miRNA) for NAFLD progression. A systems biology approach by combining differential expression analysis and weighted gene co-expression network analysis (WGCNA) was utilized to dissect transcriptional profiles in 19 normal, 10 NAFL and 16 NASH patients. Based on this framework, 3 modules related to chromosome organization, proteasomal ubiquitin-dependent protein degradation and immune response were identified in NASH network. Furthermore, 9 modules of co-expressed genes associated with NAFL/NASH transition were found. Further characterization of these modules defined 13 highly connected hub genes in NAFLD progression network. Interestingly, 11 significantly changed miRNAs were predicted to target 10 of the 13 hub genes. Characterization of modules and hub genes that may be regulated by miRNAs could facilitate the identification of candidate genes and pathways responsible for NAFL/NASH transition and lead to a better understanding of NAFLD pathogenesis. The identified modules and hub genes may point to potential targets for therapeutic interventions.
引用
收藏
页码:1793 / 1804
页数:12
相关论文
共 50 条
  • [31] Nonalcoholic Fatty Liver Disease
    Law, Kathryn
    Brunt, Elizabeth M.
    CLINICS IN LIVER DISEASE, 2010, 14 (04) : 591 - +
  • [33] The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
    Sharma, Mithun
    Mitnala, Shasikala
    Vishnubhotla, Ravi K.
    Mukherjee, Rathin
    Reddy, Duvvur N.
    Rao, Padaki N.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (02) : 147 - 158
  • [34] Optimization of Human Liver Organoid Model for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Park, Y.
    Thadasina, D.
    Isidan, K.
    Lopez, K. J.
    Cross-Najafi, A.
    Li, P.
    Francis, H.
    Alpini, G.
    Zhang, W.
    Ekser, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 413 - 413
  • [35] Liver gene regulatory networks: Contributing factors to nonalcoholic fatty liver disease
    Cebola, Ines
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2020, 12 (03)
  • [36] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
    Carter, Danielle
    Dieterich, Douglas T.
    Chang, Charissa
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 213 - +
  • [37] Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease
    Cerovic, Ivana
    Mladenovic, Dusan
    Jesic, Rada
    Naumovic, Tamara
    Brankovic, Milos
    Vucevic, Danijela
    Aleksic, Vuk
    Radosavljevic, Tatjana
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (08) : 899 - 904
  • [38] Metabolomic classification of murine and human nonalcoholic fatty liver disease
    Alonso, Cristina
    Lavine, Jose L.
    Iruarrizaga-Lejarreta, Marta
    Fernandez, David
    van Liempd, Sebastiaan
    delaCruz-Villar, Laura
    Navasa, Nicolas
    Martinez-Arranz, Ibon
    Aurrecoechea, Igor
    Buque, Xavier
    Varela, Marta
    Falcon-Perez, Juan M.
    Newberry, Elizabeth P.
    Aspichueta, Patricia
    Aransay, Ana M.
    Noureddin, Mazen
    Anguita, Juan
    Davidson, Nicholas O.
    Martinez-Chantar, Maria L.
    Lu, Shelly C.
    Mato, Jose M.
    HEPATOLOGY, 2016, 64 : 794A - 795A
  • [39] Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    De Munck, Toon J. I.
    Boesch, Markus
    Verhaegh, Pauline
    Masclee, Ad A. M.
    Jonkers, Daisy
    van Pelt, Jos F.
    du Plessis, Johannie
    Korf, Hannelie
    Nevens, Frederik
    Koek, Ger H.
    Van der Merwe, Schalk
    Verbeek, Jef
    PLOS ONE, 2021, 16 (05):
  • [40] Activation of the Complement System in Human Nonalcoholic Fatty Liver Disease
    Rensen, Sander S.
    Slaats, Yanti
    Driessen, Ann
    Peutz-Kootstra, Carine J.
    Nijhuis, Jeroen
    Steffensen, Rudi
    Greve, Jan Willem
    Buurman, Wim A.
    HEPATOLOGY, 2009, 50 (06) : 1809 - 1817